159837 生物科技
已收盘 11-22 15:00:00
资讯
新帖
简况
港股午评：恒生指数半日跌0.12% 汽车、煤炭、内银股跌幅居前
美港电讯 · 11-20
港股午评：恒生指数半日跌0.12% 汽车、煤炭、内银股跌幅居前
宽松利率环境下或有出色表现，美股生物科技股企稳反弹，标普生物科技ETF早盘涨0.9%
每日经济新闻 · 11-20
宽松利率环境下或有出色表现，美股生物科技股企稳反弹，标普生物科技ETF早盘涨0.9%
陈茂波：香港正致力与大湾区城市合作 特别聚焦人工智能、生物科技及新材料等领域
智通财经网 · 11-19
陈茂波：香港正致力与大湾区城市合作 特别聚焦人工智能、生物科技及新材料等领域
香港证监会主席黄天佑：积极与亚洲及一带一路地区深化联系，认可国际交易所数量增至19家
金十财经 · 11-18
香港证监会主席黄天佑：积极与亚洲及一带一路地区深化联系，认可国际交易所数量增至19家
众生药业：昂拉地韦颗粒Ⅱ期临床试验完成首例参与者入组和给药
美港电讯 · 11-17
众生药业：昂拉地韦颗粒Ⅱ期临床试验完成首例参与者入组和给药
花旗推荐吉利德和Vertex为生物科技新兴大买入标的
华尔街洞察 · 11-15
花旗推荐吉利德和Vertex为生物科技新兴大买入标的
东方生物：获得医疗器械注册证及新兽药证书
美港电讯 · 11-14
东方生物：获得医疗器械注册证及新兽药证书
亚香股份(301220.SZ)：亚香生物科技(泰国)有限公司生产基地项目一期已投产
智通财经 · 11-11
亚香股份(301220.SZ)：亚香生物科技(泰国)有限公司生产基地项目一期已投产
联邦生物科技（珠海横琴）有限公司被认定为“横琴粤澳深度合作区生物医药大健康标杆项目”
联邦制药 · 11-07
联邦生物科技（珠海横琴）有限公司被认定为“横琴粤澳深度合作区生物医药大健康标杆项目”
倪斌的华安恒生香港上市生物科技指数发起式(QDII)A（021658）值得买吗？
证券之星 · 11-04
倪斌的华安恒生香港上市生物科技指数发起式(QDII)A（021658）值得买吗？
绿新亲水胶体：厦门蓝海藻膜生物科技获漳州市龙海区新湾注资6385万元
智通财经 · 10-31
绿新亲水胶体：厦门蓝海藻膜生物科技获漳州市龙海区新湾注资6385万元
绿新亲水胶体(01084)：厦门蓝海藻膜生物科技获漳州市龙海区新湾注资6385万元
智通财经网 · 10-31
绿新亲水胶体(01084)：厦门蓝海藻膜生物科技获漳州市龙海区新湾注资6385万元
阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段
美港电讯 · 10-30
阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段
ST合一康出资51万元成立上海合熠康生物科技有限公司，持股51%
金融界 · 10-29
ST合一康出资51万元成立上海合熠康生物科技有限公司，持股51%
美康生物、润达医疗等成立生物科技公司
美港电讯 · 10-25
美康生物、润达医疗等成立生物科技公司
梅花生物：业绩短期承压 生物科技促成长
国联证券 · 10-24
梅花生物：业绩短期承压 生物科技促成长
浩欧博：控股股东筹划股份转让事项 股票停牌
美港电讯 · 10-23
浩欧博：控股股东筹划股份转让事项 股票停牌
爱博医疗：控股子公司烟台德胜海洋生物科技有限公司主要进行医用材料相关研发和生产工作，亦有原料销售业务
每日经济新闻 · 10-16
爱博医疗：控股子公司烟台德胜海洋生物科技有限公司主要进行医用材料相关研发和生产工作，亦有原料销售业务
礼来(LLY.US)投资目光转向欧洲 向英国生物科技领域投资3.6亿美元
智通财经网 · 10-14
礼来(LLY.US)投资目光转向欧洲 向英国生物科技领域投资3.6亿美元
应急管理部派工作组赴山东寿光一企业中毒事故现场
金十财经 · 10-13
应急管理部派工作组赴山东寿光一企业中毒事故现场
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159837","market":"SZ","secType":"STK","nameCN":"生物科技","latestPrice":0.454,"timestamp":1732258989000,"preClose":0.472,"halted":0,"volume":69860104,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.018,"latestTime":"11-22 15:00:00","open":0.472,"high":0.472,"low":0.453,"amount":32279800,"amplitude":0.0403,"askPrice":0.455,"askSize":21,"bidPrice":0.454,"bidSize":971,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":0.472,"symbolType":"fund","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":0.519,"lowLimit":0.425,"ibTradeSell":false,"ibTradeBuySell":true,"pbRate":0,"committee":0.912047,"marketValue":0,"floatMarketCap":0,"changeRate":-0.0381,"turnoverRate":0,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-11-25。","discountRate":"0.00%","netWorth":"0.000"},"requestUrl":"/m/hq/s/159837","defaultTab":"news","newsList":[{"id":"2484132302","title":"港股午评：恒生指数半日跌0.12% 汽车、煤炭、内银股跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2484132302","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484132302?lang=zh_cn&edition=full","pubTime":"2024-11-20 12:07","pubTimestamp":1732075635,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999001093.SGD","89888","SGXZ90724238.SGD","601633","LU0359201885.HKD","SG9999002828.SGD","02333","03086","JD","LU1282648689.USD","159837","HSTECH","HHImain","07226","000488","00700","01024","09866","09618","159938","82333","80700","HTCD.SI","LU1044875133.USD","02833","LU1105468828.SGD","01812","GWLLY","LU0880133367.SGD","LU0049853897.USD","TTTN","BK1588","89618","513600","MCHmain","LU0348814723.USD","81024","MHImain","HSCEI","TCEHY","YANG","09888","HSI","HSImain","BK1095","159582","161032","09939","BIDU"],"gpt_icon":0},{"id":"2484132234","title":"宽松利率环境下或有出色表现，美股生物科技股企稳反弹，标普生物科技ETF早盘涨0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484132234","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484132234?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:51","pubTimestamp":1732074660,"startTime":"0","endTime":"0","summary":"近期持续调整的美股生物科技股周二企稳反弹，INSMED涨超10%，NATERA、SUMMIT THERAPEUTICS等涨超5%，艾伯维、安进等止跌回升。受盘面影响，标普生物科技ETF今日早盘上涨0.9%。有券商表示，2024年全球利率进入下行通道，宽松的利率环境会进一步降低科技及创新药企业的投融资成本及研发成本，形成正向循环。资料显示，标普生物科技ETF跟踪标普生物技术精选行业，与美国知名的生物科技ETF跟踪同一指数，是目前A股中唯一跟踪该指数的ETF。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/us/2024-11-20/doc-incwspws5519548.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2024-11-20/doc-incwspws5519548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["TNmain","ZNmain","ZTmain","515000","UBmain","161127","ZBmain","ZFmain","159837"],"gpt_icon":0},{"id":"2484999849","title":"陈茂波：香港正致力与大湾区城市合作 特别聚焦人工智能、生物科技及新材料等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2484999849","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484999849?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:10","pubTimestamp":1732003806,"startTime":"0","endTime":"0","summary":"陈茂波又称，香港正致力发展东盟在内全球南方市场，认为区内增长迅速，中产阶级持续增长，企业持续寻找资金扩张，认为在地缘政治局势变化下，区内亦希望寻求加强与香港联系。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20241119/20241119161049_46689.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241119/20241119161049_46689.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["161631","159983","159837","159703"],"gpt_icon":0},{"id":"2484984626","title":"香港证监会主席黄天佑：积极与亚洲及一带一路地区深化联系，认可国际交易所数量增至19家","url":"https://stock-news.laohu8.com/highlight/detail?id=2484984626","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484984626?lang=zh_cn&edition=full","pubTime":"2024-11-18 11:11","pubTimestamp":1731899497,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["07226","HSCEI","159837","YANG","168201","399991","HSTECH","159822"],"gpt_icon":0},{"id":"2484891396","title":"众生药业：昂拉地韦颗粒Ⅱ期临床试验完成首例参与者入组和给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2484891396","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484891396?lang=zh_cn&edition=full","pubTime":"2024-11-17 18:41","pubTimestamp":1731840110,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002317","BK1576","159837","BK0188","159992","BK1583","BK1161","BK1141","BK0077","BK1574","06978","03347","BK0239"],"gpt_icon":0},{"id":"1118850472","title":"花旗推荐吉利德和Vertex为生物科技新兴大买入标的","url":"https://stock-news.laohu8.com/highlight/detail?id=1118850472","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118850472?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:12","pubTimestamp":1731636736,"startTime":"0","endTime":"0","summary":"$花旗$银行将$吉利德科学$公司和Vertex制药公司列为“买入”评级，认为前者将受益于抗病毒药物Biktarvy的短期增长和新药Sunlenca的长期增长。Vertex预计将继续保持在囊性纤维化治疗市场的领导地位，并在急性疼痛领域拓展其新药Suzetrigine，预计FDA将在2025年1月30日决定其审批结果。花旗为吉利德设定的目标价为125美元，而Vertex的目标价为575美元。对于Vertex，花旗预计其囊性纤维化药物Vanza三联疗法将在2030年实现80亿美元的风险调整后峰值销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU1366192091.USD","LU2125154778.USD","IE00B19Z3581.USD","LU0320765992.SGD","LU0128525689.USD","C","VERX","LU0417517546.SGD","BK4207","LU2360032135.SGD","LU0109394709.USD","LU0079474960.USD","VRTX","LU0130517989.USD","LU1267930227.SGD","BK4588","IE00BSNM7G36.USD","LU1162221912.USD","159837"],"gpt_icon":0},{"id":"2483840122","title":"东方生物：获得医疗器械注册证及新兽药证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2483840122","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483840122?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:56","pubTimestamp":1731574610,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688298","BK1222","LU0029874061.USD","BK1100","LU0128526141.USD","BK4135","159883","159837","09997","BK1583","09996","BK1574","BK4590","AB","BK0239"],"gpt_icon":0},{"id":"2482240661","title":"亚香股份(301220.SZ)：亚香生物科技(泰国)有限公司生产基地项目一期已投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2482240661","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482240661?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:19","pubTimestamp":1731298746,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚香股份(301220.SZ)发布公告，截至本公告日，募投项目“亚香生物科技(泰国)有限公司生产基地项目”项目一期经过前期试生产，已完成对生产工艺、机器设备的安装调试，相关产线于近日正式投产。本次募投项目投产后，公司将新增香兰素1000吨、橡苔200吨、苯甲醛100吨、苯甲醇50吨、桂酸甲酯100吨、凉味剂150吨、叶醇150吨产能。有助于巩固并扩大公司在香精香料行业的市场份额和市场地位，增强公司的盈利能力和市场竞争力，对公司的经营业绩具有积极的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301220","159837","BK0229"],"gpt_icon":0},{"id":"2481920630","title":"联邦生物科技（珠海横琴）有限公司被认定为“横琴粤澳深度合作区生物医药大健康标杆项目”","url":"https://stock-news.laohu8.com/highlight/detail?id=2481920630","media":"联邦制药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481920630?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:16","pubTimestamp":1730971010,"startTime":"0","endTime":"0","summary":"11月6日，横琴粤澳深度合作区官网发布了关于认定横琴粤澳深度合作区生物医药大健康产业标杆项目、公共服务平台的通知。联邦生物科技（珠海横琴）有限公司被认定为“2022年度横琴粤澳深度合 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241107/c663295803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159837","399441","161726"],"gpt_icon":0},{"id":"2480031188","title":"倪斌的华安恒生香港上市生物科技指数发起式(QDII)A（021658）值得买吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2480031188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480031188?lang=zh_cn&edition=full","pubTime":"2024-11-04 08:01","pubTimestamp":1730678496,"startTime":"0","endTime":"0","summary":"持有期间的估算收益率为35.25%，持有期间比亚迪在2021年到2024年的中报归属净利润增幅达1061.52%。通过分析以上基金经理历史上的重仓股调仓操作案例，我们可以看出基金经理倪斌的阿尔法能力普通，华安恒生香港上市生物科技指数发起式A基金的盈利能力还有待后续观察。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400001441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","BK0217","300785"],"gpt_icon":0},{"id":"2479083019","title":"绿新亲水胶体：厦门蓝海藻膜生物科技获漳州市龙海区新湾注资6385万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479083019","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479083019?lang=zh_cn&edition=full","pubTime":"2024-10-31 19:54","pubTimestamp":1730375660,"startTime":"0","endTime":"0","summary":"绿新亲水胶体(01084)发布公告，于2024年10月31日，投资者(漳州市龙海区新湾)、绿新(公司间接全资附属公司)、厦门迅翼财及翁武银先生订立投资协议，投资者同意向目标公司厦门蓝海藻膜生物科 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241031/c663049715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159837"],"gpt_icon":0},{"id":"2479708868","title":"绿新亲水胶体(01084)：厦门蓝海藻膜生物科技获漳州市龙海区新湾注资6385万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479708868","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479708868?lang=zh_cn&edition=full","pubTime":"2024-10-31 19:52","pubTimestamp":1730375533,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿新亲水胶体 发布公告，于2024年10月31日，投资者、绿新、厦门迅翼财及翁武银先生订立投资协议，投资者同意向目标公司厦门蓝海藻膜生物科技有限公司注资最多人民币6385万元且绿新已同意同时向目标公司注资人民币2777万元。根据投资协议，投资者已获授予回购选择权，当发生任何赎回事件时，绿新须按回购价购买投资者于目标公司的全部股权。因此，本公司于目标公司的权益将由 60.00%摊薄至约46.68%，减少13.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1129","159837","01084"],"gpt_icon":0},{"id":"2479184562","title":"阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2479184562","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479184562?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:39","pubTimestamp":1730255969,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","03347","159992","688621","BK1574","BK1576","06978","BK1583","159837","CAR","BK1515","BK4077","SLE","BK4022","09939","BK4230","159938","BK0216","BK1161"],"gpt_icon":0},{"id":"2479945977","title":"ST合一康出资51万元成立上海合熠康生物科技有限公司，持股51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479945977","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479945977?lang=zh_cn&edition=full","pubTime":"2024-10-29 03:44","pubTimestamp":1730144654,"startTime":"0","endTime":"0","summary":"天眼查工商信息显示，近日，深圳市合一康生物科技股份有限公司出资51万元成立上海合熠康生物科技有限公司，持股51%，所属行业为研究和试验发展。资料显示，上海合熠康生物科技有限公司成立 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20241029/c662895061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159837"],"gpt_icon":0},{"id":"2478624577","title":"美康生物、润达医疗等成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2478624577","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478624577?lang=zh_cn&edition=full","pubTime":"2024-10-25 13:47","pubTimestamp":1729835234,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1100","300439","BK0042","09996","BK0046","BK1583","159837","09997","603108","BK0239","BK0250","BK1222","BK1574","159883"],"gpt_icon":0},{"id":"2477525826","title":"梅花生物：业绩短期承压 生物科技促成长","url":"https://stock-news.laohu8.com/highlight/detail?id=2477525826","media":"国联证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477525826?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:00","pubTimestamp":1729699200,"startTime":"0","endTime":"0","summary":"味精、豆粕跌价拖累，业绩略低于预期三季度业绩下滑主要是味精、黄原胶、淀粉副产品价格下降，及第三季度财务和研发费用环比增加逾5000 万元所致。鉴于公司主业集中度较高、盈利较为稳定，并且重点布局合成生物学打开成长空间，我们维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410241256239f58a7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410241256239f58a7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0033","BK0226","BK0012","BK0070","159837","BK0028","600873"],"gpt_icon":0},{"id":"2477030935","title":"浩欧博：控股股东筹划股份转让事项 股票停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2477030935","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477030935?lang=zh_cn&edition=full","pubTime":"2024-10-23 18:00","pubTimestamp":1729677636,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","688656","159837"],"gpt_icon":0},{"id":"2475695302","title":"爱博医疗：控股子公司烟台德胜海洋生物科技有限公司主要进行医用材料相关研发和生产工作，亦有原料销售业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2475695302","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475695302?lang=zh_cn&edition=full","pubTime":"2024-10-16 17:18","pubTimestamp":1729070292,"startTime":"0","endTime":"0","summary":"3，德胜海洋生物是否会作为原料商向第三方公司销售原料商品？是否已有销售额？爱博医疗10月16日在投资者互动平台表示，根据2024年半年度报告，截至2024年6月30日，公司的高透氧硅水凝胶材质软性隐形眼镜、非球面三焦散光矫正人工晶状体、数款注射用透明质酸钠凝胶正处于临床实验阶段。公司控股子公司烟台德胜海洋生物科技有限公司主要进行医用材料相关研发和生产工作，亦有原料销售业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410161719259f474d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410161719259f474d71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159837","688050","BK0251"],"gpt_icon":0},{"id":"2475367811","title":"礼来(LLY.US)投资目光转向欧洲 向英国生物科技领域投资3.6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475367811","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475367811?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:44","pubTimestamp":1728913459,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国医药巨头礼来公司计划投资约2.79亿英镑用于一项新的投资举措，主要在于支持英国国内的多家生物科技公司协同发展，并且还将在英国研究其治疗糖尿病和肥胖症的重磅药物对英国医疗资源使用以及就业状况等方面的影响。英国政府虽然长期以来致力于将该国定位为“生命科学超级大国”，但长期难以吸引和留住投资。Mounjaro使用者12个月的平均体重减轻15.3%，而Ozempic使用者的平均体重减轻8.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1193823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0256863902.USD","BK4585","LU0097036916.USD","IE00BFTCPJ56.SGD","BK4534","LU0198837287.USD","LU0820561909.HKD","LU1023059063.AUD","LU0122379950.USD","LU1035775433.USD","159837","LU0079474960.USD","IE00BK4W5L77.USD","LU0320765059.SGD","LU0061475181.USD","LU0006306889.USD","LU0466842654.USD","LU0882574139.USD","LU0109391861.USD","IE0002141913.USD","IE00BK4W5M84.HKD","LU1064131342.USD","BK4533","LU0354030511.USD","LU0820561818.USD","BK4516","IE00B1BXHZ80.USD","BK4588","BK4581","LU0114720955.EUR","LU0689472784.USD","LU0471298777.SGD","LU0354030438.USD","LU0289739699.SGD","LU1069344957.HKD","LU0456855351.SGD","LU1057294990.SGD","LLY","LU0417517546.SGD","LU1267930730.SGD","IE00BJJMRZ35.SGD","LU0094547139.USD","LU0823416689.USD","LU0882574055.USD","LU0708995401.HKD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0238689110.USD","LU0943347566.SGD","GB00BDT5M118.USD"],"gpt_icon":1},{"id":"2475812413","title":"应急管理部派工作组赴山东寿光一企业中毒事故现场","url":"https://stock-news.laohu8.com/highlight/detail?id=2475812413","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475812413?lang=zh_cn&edition=full","pubTime":"2024-10-13 17:52","pubTimestamp":1728813168,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["159837"],"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0361},{"period":"3month","weight":0.1792},{"period":"6month","weight":0.0318},{"period":"1year","weight":-0.1893},{"period":"ytd","weight":-0.1482}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"serverTime":1732359034875,"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,159837,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}